Skip to main content
Top
Published in: Radiation Oncology 1/2023

Open Access 01-12-2023 | Research

IMPT of head and neck cancer: unsupervised machine learning treatment planning strategy for reducing radiation dermatitis

Authors: Noufal Manthala Padannayil, Dayananda Shamurailatpam Sharma, Sapna Nangia, Kartikeshwar C. Patro, Utpal Gaikwad, Nagarjuna Burela

Published in: Radiation Oncology | Issue 1/2023

Login to get access

Abstract

Radiation dermatitis is a major concern in intensity modulated proton therapy (IMPT) for head and neck cancer (HNC) despite its demonstrated superiority over contemporary photon radiotherapy. In this study, dose surface histogram data extracted from forty-four patients of HNC treated with IMPT was used to predict the normal tissue complication probability (NTCP) of skin. Grades of NTCP-skin were clustered using the K-means clustering unsupervised machine learning (ML) algorithm. A new skin-sparing IMPT (IMPT-SS) planning strategy was developed with three major changes and prospectively implemented in twenty HNC patients. Across skin surfaces exposed from 10 (S10) to 70 (S70) GyRBE, the skin's NTCP demonstrated the strongest associations with S50 and S40 GyRBE (0.95 and 0.94). The increase in the NTCP of skin per unit GyRBE is 0.568 for skin exposed to 50 GyRBE as compared to 0.418 for 40 GyRBE. Three distinct clusters were formed, with 41% of patients in G1, 32% in G2, and 27% in G3. The average (± SD) generalised equivalent uniform dose for G1, G2, and G3 clusters was 26.54 ± 6.75, 38.73 ± 1.80, and 45.67 ± 2.20 GyRBE. The corresponding NTCP (%) were 4.97 ± 5.12, 48.12 ± 12.72 and 87.28 ± 7.73 respectively. In comparison to IMPT, new IMPT-SS plans significantly (P < 0.01) reduced SX GyRBE, gEUD, and associated NTCP-skin while maintaining identical dose volume indices for target and other organs at risk. The mean NTCP-skin value for IMPT-SS was 34% lower than that of IMPT. The dose to skin in patients treated prospectively for HNC was reduced by including gEUD for an acceptable radiation dermatitis determined from the local patient population using an unsupervised MLA in the spot map optimization of a new IMPT planning technique. However, the clinical finding of acute skin toxicity must also be related to the observed reduction in skin dose.
Literature
1.
go back to reference Leeman JE, Romesser PB, Zhou Y, McBride S, Riaz N, Sherman E, Cohen MA, Cahlon O, Lee N. Proton therapy for head and neck cancer: expanding the therapeutic window. Lancet Oncol. 2017;18(5):e254–65.CrossRef Leeman JE, Romesser PB, Zhou Y, McBride S, Riaz N, Sherman E, Cohen MA, Cahlon O, Lee N. Proton therapy for head and neck cancer: expanding the therapeutic window. Lancet Oncol. 2017;18(5):e254–65.CrossRef
2.
go back to reference Beddok A, Vela A, Calugaru V, Tessonnier T, Kubes J, Dutheil P, Gerard A, Vidal M, Goudjil F, Florescu C, Kammerer E, Benezery K, Herault J, Poortmans P, Bourhis J, Thariat J; GORTEC, the 3 French proton centers. Proton therapy for head and neck squamous cell carcinomas: A review of the physical and clinical challenges. Radiother Oncol. 2020; 147:30–39. Beddok A, Vela A, Calugaru V, Tessonnier T, Kubes J, Dutheil P, Gerard A, Vidal M, Goudjil F, Florescu C, Kammerer E, Benezery K, Herault J, Poortmans P, Bourhis J, Thariat J; GORTEC, the 3 French proton centers. Proton therapy for head and neck squamous cell carcinomas: A review of the physical and clinical challenges. Radiother Oncol. 2020; 147:30–39.
3.
go back to reference Steneker M, Lomax A, Schneider U. Intensity modulated photon and proton therapy for the treatment of head and neck tumors. Radiother Oncol. 2006;80(2):263–7.CrossRef Steneker M, Lomax A, Schneider U. Intensity modulated photon and proton therapy for the treatment of head and neck tumors. Radiother Oncol. 2006;80(2):263–7.CrossRef
4.
go back to reference Kandula S, Zhu X, Garden AS, Gillin M, Rosenthal DI, Ang KK, Mohan R, Amin MV, Garcia JA, Wu R, Sahoo N, Frank SJ. Spot-scanning beam proton therapy vs intensity-modulated radiation therapy for ipsilateral head and neck malignancies: a treatment planning comparison. Med Dosim. 2013;38(4):390–4.CrossRef Kandula S, Zhu X, Garden AS, Gillin M, Rosenthal DI, Ang KK, Mohan R, Amin MV, Garcia JA, Wu R, Sahoo N, Frank SJ. Spot-scanning beam proton therapy vs intensity-modulated radiation therapy for ipsilateral head and neck malignancies: a treatment planning comparison. Med Dosim. 2013;38(4):390–4.CrossRef
5.
go back to reference Holliday EB, Frank SJ. Proton therapy for nasopharyngeal carcinoma. Chin Clin Oncol. 2016;5(2):25.CrossRef Holliday EB, Frank SJ. Proton therapy for nasopharyngeal carcinoma. Chin Clin Oncol. 2016;5(2):25.CrossRef
6.
go back to reference Vai A, Molinelli S, Rossi E, Iacovelli NA, Magro G, Cavallo A, Pignoli E, Rancati T, Mirandola A, Russo S, Ingargiola R, Vischioni B, Bonora M, Ronchi S, Ciocca M, Orlandi E. Proton radiation therapy for nasopharyngeal cancer patients: dosimetric and NTCP evaluation supporting clinical decision. Cancers (Basel). 2022;14(5):1109.CrossRef Vai A, Molinelli S, Rossi E, Iacovelli NA, Magro G, Cavallo A, Pignoli E, Rancati T, Mirandola A, Russo S, Ingargiola R, Vischioni B, Bonora M, Ronchi S, Ciocca M, Orlandi E. Proton radiation therapy for nasopharyngeal cancer patients: dosimetric and NTCP evaluation supporting clinical decision. Cancers (Basel). 2022;14(5):1109.CrossRef
7.
go back to reference Romesser PB, Cahlon O, Scher E, Zhou Y, Berry SL, Rybkin A, Sine KM, Tang S, Sherman EJ, Wong R, Lee NY. Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation. Radiother Oncol. 2016;118(2):286–92.CrossRef Romesser PB, Cahlon O, Scher E, Zhou Y, Berry SL, Rybkin A, Sine KM, Tang S, Sherman EJ, Wong R, Lee NY. Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation. Radiother Oncol. 2016;118(2):286–92.CrossRef
8.
go back to reference Rombi B, DeLaney TF, MacDonald SM, Huang MS, Ebb DH, Liebsch NJ, Raskin KA, Yeap BY, Marcus KJ, Tarbell NJ, Yock TI. Proton radiotherapy for pediatric Ewing’s sarcoma: initial clinical outcomes. Int J Radiat Oncol Biol Phys. 2012;82(3):1142–8.CrossRef Rombi B, DeLaney TF, MacDonald SM, Huang MS, Ebb DH, Liebsch NJ, Raskin KA, Yeap BY, Marcus KJ, Tarbell NJ, Yock TI. Proton radiotherapy for pediatric Ewing’s sarcoma: initial clinical outcomes. Int J Radiat Oncol Biol Phys. 2012;82(3):1142–8.CrossRef
9.
go back to reference Bush DA, Slater JD, Garberoglio C, Do S, Lum S, Slater JM. Partial breast irradiation delivered with proton beam: results of a phase II trial. Clin Breast Cancer. 2011;11(4):241–5.CrossRef Bush DA, Slater JD, Garberoglio C, Do S, Lum S, Slater JM. Partial breast irradiation delivered with proton beam: results of a phase II trial. Clin Breast Cancer. 2011;11(4):241–5.CrossRef
10.
go back to reference Moskvin V, Lasley FD, Ray GL, et al. Acute skin toxicity associated with proton beam therapy in spine and brain patients. J Radiat Oncol. 2014;3:195–203.CrossRef Moskvin V, Lasley FD, Ray GL, et al. Acute skin toxicity associated with proton beam therapy in spine and brain patients. J Radiat Oncol. 2014;3:195–203.CrossRef
11.
go back to reference Duncan W, MacDougall RH, Kerr GR, Downing D. Adverse effect of treatment gaps in the outcome of radiotherapy for laryngeal cancer. Radiother Oncol. 1996;41(3):203–7.CrossRef Duncan W, MacDougall RH, Kerr GR, Downing D. Adverse effect of treatment gaps in the outcome of radiotherapy for laryngeal cancer. Radiother Oncol. 1996;41(3):203–7.CrossRef
12.
go back to reference Robertson C, Robertson AG, Hendry JH, Roberts SA, Slevin NJ, Duncan WB, MacDougall RH, Kerr GR, O’Sullivan B, Keane TJ. Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers. Int J Radiat Oncol Biol Phys. 1998;40(2):319–29.CrossRef Robertson C, Robertson AG, Hendry JH, Roberts SA, Slevin NJ, Duncan WB, MacDougall RH, Kerr GR, O’Sullivan B, Keane TJ. Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers. Int J Radiat Oncol Biol Phys. 1998;40(2):319–29.CrossRef
13.
go back to reference Fesinmeyer MD, Mehta V, Blough D, Tock L, Ramsey SD. Effect of radiotherapy interruptions on survival in medicare enrollees with local and regional head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2010;78(3):675–81.CrossRef Fesinmeyer MD, Mehta V, Blough D, Tock L, Ramsey SD. Effect of radiotherapy interruptions on survival in medicare enrollees with local and regional head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2010;78(3):675–81.CrossRef
14.
go back to reference Pastore F, Conson M, D’Avino V, Palma G, Liuzzi R, Solla R, Farella A, Salvatore M, Cella L, Pacelli R. Dose-surface analysis for prediction of severe acute radio-induced skin toxicity in breast cancer patients. Acta Oncol. 2016;55(4):466–73.CrossRef Pastore F, Conson M, D’Avino V, Palma G, Liuzzi R, Solla R, Farella A, Salvatore M, Cella L, Pacelli R. Dose-surface analysis for prediction of severe acute radio-induced skin toxicity in breast cancer patients. Acta Oncol. 2016;55(4):466–73.CrossRef
15.
go back to reference Palma G, Cella L. A new formalism of Dose Surface Histograms for robust modeling of skin toxicity in radiation therapy. Phys Med. 2019;59:75–8.CrossRef Palma G, Cella L. A new formalism of Dose Surface Histograms for robust modeling of skin toxicity in radiation therapy. Phys Med. 2019;59:75–8.CrossRef
16.
go back to reference Mori M, Cattaneo GM, Dell’Oca I, Foti S, Calandrino R, Di Muzio NG, Fiorino C. Skin DVHs predict cutaneous toxicity in Head and Neck Cancer patients treated with Tomotherapy. Phys Med. 2019;59:133–41.CrossRef Mori M, Cattaneo GM, Dell’Oca I, Foti S, Calandrino R, Di Muzio NG, Fiorino C. Skin DVHs predict cutaneous toxicity in Head and Neck Cancer patients treated with Tomotherapy. Phys Med. 2019;59:133–41.CrossRef
17.
go back to reference Kawamura M, Yoshimura M, Asada H, Nakamura M, Matsuo Y, Mizowaki T. A scoring system predicting acute radiation dermatitis in patients with head and neck cancer treated with intensity-modulated radiotherapy. Radiat Oncol. 2019;14(1):14.CrossRef Kawamura M, Yoshimura M, Asada H, Nakamura M, Matsuo Y, Mizowaki T. A scoring system predicting acute radiation dermatitis in patients with head and neck cancer treated with intensity-modulated radiotherapy. Radiat Oncol. 2019;14(1):14.CrossRef
18.
go back to reference Palma G, Monti S, Conson M, Xu T, Hahn S, Durante M, Mohan R, Liao Z, Cella L. NTCP models for severe radiation induced dermatitis after IMRT or proton therapy for thoracic cancer patients. Front Oncol. 2020;10:344.CrossRef Palma G, Monti S, Conson M, Xu T, Hahn S, Durante M, Mohan R, Liao Z, Cella L. NTCP models for severe radiation induced dermatitis after IMRT or proton therapy for thoracic cancer patients. Front Oncol. 2020;10:344.CrossRef
19.
go back to reference Moskvin VP, Estabrook NC, Cheng CW, Das IJ, Johnstone PA. Effect of scanning beam for superficial dose in proton therapy. Technol Cancer Res Treat. 2015;14(5):643–52.CrossRef Moskvin VP, Estabrook NC, Cheng CW, Das IJ, Johnstone PA. Effect of scanning beam for superficial dose in proton therapy. Technol Cancer Res Treat. 2015;14(5):643–52.CrossRef
20.
go back to reference Arjomandy B, Sahoo N, Cox J, Lee A, Gillin M. Comparison of surface doses from spot scanning and passively scattered proton therapy beams. Phys Med Biol. 2009;54(14):N295-302.CrossRef Arjomandy B, Sahoo N, Cox J, Lee A, Gillin M. Comparison of surface doses from spot scanning and passively scattered proton therapy beams. Phys Med Biol. 2009;54(14):N295-302.CrossRef
21.
go back to reference Zhu A, Hua Z, Shi Y, Tang Y, Miao L. An improved K-means algorithm based on evidence distance. Entropy (Basel). 2021;23(11):1550.CrossRef Zhu A, Hua Z, Shi Y, Tang Y, Miao L. An improved K-means algorithm based on evidence distance. Entropy (Basel). 2021;23(11):1550.CrossRef
22.
go back to reference Shamurailatpam DS, Manikandan A, Ganapathy K, Noufal MP, Patro KC, Rajesh T, Jalali R. Characterization and performance evaluation of the first-proton therapy facility in India. J Med Phys. 2020;45(2):59–65.CrossRef Shamurailatpam DS, Manikandan A, Ganapathy K, Noufal MP, Patro KC, Rajesh T, Jalali R. Characterization and performance evaluation of the first-proton therapy facility in India. J Med Phys. 2020;45(2):59–65.CrossRef
23.
go back to reference Noufal MP, Sharma SD, Patro K, Arjunan M, Krishnan G, Tyagarajan R, Rana S, Chillukuri S, Jalali R. Impact of spot positional errors in robustly optimized intensity-modulated proton therapy plan of craniospinal irradiation. Radiol Phys Technol. 2021;14(3):271–8.CrossRef Noufal MP, Sharma SD, Patro K, Arjunan M, Krishnan G, Tyagarajan R, Rana S, Chillukuri S, Jalali R. Impact of spot positional errors in robustly optimized intensity-modulated proton therapy plan of craniospinal irradiation. Radiol Phys Technol. 2021;14(3):271–8.CrossRef
24.
go back to reference Chen H, Craft DL, Gierga DP. Multicriteria optimization informed VMAT planning. Med Dosim. 2014;39(1):64–73.CrossRef Chen H, Craft DL, Gierga DP. Multicriteria optimization informed VMAT planning. Med Dosim. 2014;39(1):64–73.CrossRef
25.
go back to reference van de Water S, van Dam I, Schaart DR, Al-Mamgani A, Heijmen BJ, Hoogeman MS. The price of robustness; impact of worst-case optimization on organ-at-risk dose and complication probability in intensity-modulated proton therapy for oropharyngeal cancer patients. Radiother Oncol. 2016;120(1):56–62.CrossRef van de Water S, van Dam I, Schaart DR, Al-Mamgani A, Heijmen BJ, Hoogeman MS. The price of robustness; impact of worst-case optimization on organ-at-risk dose and complication probability in intensity-modulated proton therapy for oropharyngeal cancer patients. Radiother Oncol. 2016;120(1):56–62.CrossRef
26.
go back to reference Noufal MP, Widesott L, Sharma SD, Righetto R, Cianchetti M, Schwarz M. The role of plan robustness evaluation in comparing protons and photons plans—an application on IMPT and IMRT plans in skull base chordomas. J Med Phys. 2020;45(4):206–14.CrossRef Noufal MP, Widesott L, Sharma SD, Righetto R, Cianchetti M, Schwarz M. The role of plan robustness evaluation in comparing protons and photons plans—an application on IMPT and IMRT plans in skull base chordomas. J Med Phys. 2020;45(4):206–14.CrossRef
Metadata
Title
IMPT of head and neck cancer: unsupervised machine learning treatment planning strategy for reducing radiation dermatitis
Authors
Noufal Manthala Padannayil
Dayananda Shamurailatpam Sharma
Sapna Nangia
Kartikeshwar C. Patro
Utpal Gaikwad
Nagarjuna Burela
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2023
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/s13014-023-02201-y

Other articles of this Issue 1/2023

Radiation Oncology 1/2023 Go to the issue